Subscribe to RSS
DOI: 10.1055/a-2004-0683
Frühgeborenes mit Makroglossie und persistierender Hypoglykämie – Beckwith-Wiedemann-Syndrom
Preterm with Macroglossia and Persistent Hypoglycemia – Beckwith-Wiedemann Syndrome
Zusammenfassung
Das Beckwith-Wiedemann-Syndrom (BWS) ist eine genetische Erkrankung mit variablem Phänotyp, die sich mit folgenden Leitsymptomen darstellen kann: Makroglossie, Asymmetrie der Extremitäten, einseitiger Gigantismus, Vergrößerung der inneren Organe, Bauchwanddefekte, neonatale Hypoglykämie sowie einem erhöhten Risiko für embryonale Tumore. Die Prävalenz des Syndroms wird mit circa 1 von 10.000 bis 1 von 21.000 Lebendgeburten angegeben. Es beruht auf molekularen Veränderungen der Gencluster auf dem kurzen Arm von Chromosom 11, Bande P15.5. Wir stellen ein frühgeborenes Mädchen aus 32 0/7 Schwangerschaftswochen (SSW) vor. Postnatal wurde eine UPD(11)pat-Mutation diagnostiziert und damit das BWS genetisch gesichert. Die Besonderheit ihres Falls beruht auf der frühen Notwendigkeit der Zungenreduktionsplastik bei Trinkschwierigkeiten und Atemstörung sowie lang bestehenden, schwer einstellbaren Hypoglykämien.
Abstract
Beckwith-Wiedemann syndrome (BWS) is a genetic disease with phenotypic variability and the following signs: macroglossia, asymmetry, lateralised overgrowth, overgrowth of the internal organs, abdominal wall defects, neonatal hypoglycemia and increased risk of embryonic tumours. The prevalence is reported as being between 1 in 10,000 and 1 in 21,000 live births. The disease is caused by molecular changes in gene clusters on the short arm of chromosome 11 region P15.5. We present the case of a female, born preterm at 32 0/7 weeks. A UPD(11)pat-mutation was diagnosed postnatally. The particular feature of her case was an early tongue reduction surgery which was necessary because of drinking and breathing difficulties. Long-lasting hypoglycemia was difficult to treat.
Publication History
Received: 17 August 2022
Accepted after revision: 30 November 2022
Article published online:
24 January 2023
© 2023. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Brioude F, Kalish JM, Mussa A. et al. Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Endocrinol 2018; 14: 229-249 DOI: 10.1038/nrendo.2017.166.
- 2 Duffy KA, Cielo CM, Cohen JL. et al. Characterization of the Beckwith-Wiedemann spectrum: Diagnosis and management. Am J Med Genet C Semin Med Genet 2019; 181: 693-708 DOI: 10.1002/ajmg.c.31740.
- 3 Wang R, Xiao Y, Li D. et al. Clinical and molecular features of children with Beckwith-Wiedemann syndrome in China: a single-center retrospective cohort study. Ital J Pediatr 2020; 46: 55 DOI: 10.1186/s13052-020-0819-3.
- 4 Elbracht M, Prawitt D, Nemetschek R. et al. Beckwith-Wiedemann-Syndrom (BWS): Aktueller Stand der Diagnostik und des klinischen Managements. Klin Padiatr 2018; 230: 151-159 DOI: 10.1055/a-0591-9479.
- 5 Cohen JL, Cielo CM, Kupa J. et al. The Utility of Early Tongue Reduction Surgery for Macroglossia in Beckwith-Wiedemann syndrome. Plast Reconstr Surg 2020; 145: 803-813 DOI: 10.1097/PRS.0000000000006673.
- 6 Kadouch DJM, Maas SM, Dubois L. et al. Surgical treatment of macroglossia in patients with Beckwith-Wiedemann syndrome: a 20-year experience and review of the literature. Int J Oral Maxillofac Surg 2012; 41: 300-308 DOI: 10.1016/j.ijom.2011.10.021.
- 7 Brioude F, Lacoste A, Netchine I. et al. Beckwith-Wiedemann syndrome: growth pattern and tumor risk according to molecular mechanism, and guidelines for tumor surveillance. Horm Res Paediatr 2013; 80: 457-465 DOI: 10.1159/000355544.
- 8 Pettenati MJ, Haines JL, Higgins RR. et al. Wiedemann-Beckwith syndrome: presentation of clinical and cytogenetic data on 22 new cases and review of the literature. Hum Genet 1986; 74: 143-154 DOI: 10.1007/BF00282078.
- 9 Mussa A, Molinatto C, Baldassarre G. et al. Cancer Risk in Beckwith-Wiedemann syndrome: A Systematic Review and Meta-Analysis Outlining a Novel (Epi)Genotype Specific Histotype Targeted Screening Protocol. J Pediatr 2016; 176: 142-149 DOI: 10.1016/j.jpeds.2016.05.038.
- 10 Cöktü S, Spix C, Kaiser M. et al. Cancer incidence and spectrum among children with genetically confirmed Beckwith-Wiedemann spectrum in Germany: a retrospective cohort study. Br J Cancer 2020; 123: 619-623 DOI: 10.1038/s41416-020-0911-x.
- 11 DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann syndrome Registry. J Pediatr 1998; 132: 398-400 DOI: 10.1016/s0022-3476(98)70008-3.
- 12 Mussa A, Russo S, Crescenzo Ade. et al. Prevalence of Beckwith-Wiedemann yndrome in North West of Italy. Am J Med Genet A 2013; 161A: 2481-2486 DOI: 10.1002/ajmg.a.36080.
- 13 Yakoreva M, Kahre T, Žordania R. et al. A retrospective analysis of the prevalence of imprinting disorders in Estonia from 1998 to 2016. Eur J Hum Genet 2019; 27: 1649-1658 DOI: 10.1038/s41431-019-0446-x.
- 14 Wang KH, Kupa J, Duffy KA. et al. Diagnosis and Management of Beckwith-Wiedemann syndrome. Front Pediatr 2019; 7: 562 DOI: 10.3389/fped.2019.00562.